Yahoo Finance13h
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
The trial will evaluate the safety, effectiveness and ability of the shot, dubbed mRNA-1403, to induce an immune response ...
The Victoria Advocate20d
Moderna R&D Day Highlights Progress and Strategic Priorities
[10] A Phase 1 trial designed to evaluate the safety, reactogenicity and immunogenicity of a trivalent norovirus vaccinecandidate, mRNA-1403, in participants 18 to 49 years of age and 60 to 80 ...
TheDerrick.com1d
'SNL' cold open: Maya Rudolph joined by Jim Gaffigan and fellow alums Andy Samberg, Dana Carvey
"Saturday Night Live" kicked off its 50th season ready to take on the 2024 presidential campaign, and it finally revealed who was tapped to play key figures, including Minnesota Gov.
Moderna, Inc.: Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...